ESMO Congress 2024

Meet BIOTYPE at the ESMO Congress 2024!

Let’s connect at this year's ESMO Congress, which will take place September 13-17, 2024, in Barcelona, Spain and discuss how our products and services support your in-house molecular testing needs.

Solid tumor genetic testing plays a vital role in confirming, classifying and successfully treating various types of cancer. Cost- and time- effective testing is the need of the hour. The MODAPLEX platform offers researchers, pathologists, and clinicians the advantage of consolidating their testing needs for targeted panel testing – as easy as operating a PCR.

Our advanced PCR-based solutions enable targeted molecular tumor profiling and diagnostics using FFPE material or liquid biopsies. Explore our latest innovations for the rapid and precise analysis of crucial biomarkers like ESR1, POLE, and FGFR3, in accordance with current clinical guidelines.

Contact our experts Dr. Norman Gerstner, Dr. Rebekka Weissbach, or Dr. Abhishek Aich to arrange a meeting and discover our portfolio for molecular profiling and diagnostics as well as our broad range of services!